TY - JOUR T1 - Persistence of G10P[11] neonatal rotavirus infections in southern India JF - medRxiv DO - 10.1101/2021.03.01.21251320 SP - 2021.03.01.21251320 AU - Sudhir Babji AU - Kulandaipalayam Natarajan Sindhu AU - Sribal Selvarajan AU - Sasirekha Ramani AU - Srinivasan Venugopal AU - Shainey Alokit Khakha AU - Priya Hemavathy AU - Santhosh Kumar Ganesan AU - Sidhartha Giri AU - Sudhabharathi Reju AU - Krithika Gopalakrishnan AU - Binu Ninan AU - Miren Iturriza-Gomara AU - Padma Srikanth AU - Gagandeep Kang Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/02/2021.03.01.21251320.abstract N2 - Neonatal rotavirus infections are predominantly caused by distinct genotypes restricted to this age-group and are mostly asymptomatic. Stool samples from neonates admitted for >48 hours in neonatal intensive care units (NICUs) in Vellore (2014-2015) and Chennai (2015-2016) in southern India, and from neonates born at hospitals in Vellore but not admitted to NICUs (2015-2016) were tested for rotavirus by ELISA and genotyped by hemi-nested RT-PCR. Of the 791 neonates, 150 and 336 were recruited from Vellore and Chennai NICUs, and 305 were born in five hospitals in Vellore. The positivity rates in the three settings were 49.3% (74/150), 29.5% (99/336) and 54% (164/305), respectively. G10P[11] was the commonly identified genotype in 87.8% (65/74), 94.9% (94/99) and 98.2% (161/164) of the neonates in Vellore and Chennai NICUs, and those born at Vellore hospitals, respectively. Neonates delivered by lower segment caesarean section (LSCS) at Vellore hospitals, not admitted to NICUs, had a significantly higher odds of acquiring rotavirus infection compared to those delivered vaginally [p=0.002, OR=2.4 (1.4-4.3)]. This report demonstrates the persistence of G10P[11] strain in Vellore and Chennai, indicating widespread neonatal G10P[11] strain in southern India and their persistence over two decades, leading to interesting questions about strain stability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work at Christian Medical College, Vellore was funded by DBT (Department of Biotechnology (grant number BT/IN/DBT-MRC/DFID/23/GK/2015-16 dated 11.12.2015 to G.K.) India. The work was also supported by the National Institutes of Health (R01AI105101 to M.K.E., S.R., L.B. and G.K. The work at SRMC (Sri Ramachandra Medical College), Chennai was funded by ICMR-TSS (Indian Council of Medical Research -Talent Search Scheme).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies were approved by the Institutional Review Board and Ethics Committee of CMC, Vellore, for the Vellore site, and the Institutional Ethics Committee of SRMC, Chennai for the study at SRMC.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be made available on written request ER -